PL2209789T3 - Skondensowane z cyklopropylem indolobenzoazepinowe inhibitory NS5B HCV - Google Patents
Skondensowane z cyklopropylem indolobenzoazepinowe inhibitory NS5B HCVInfo
- Publication number
- PL2209789T3 PL2209789T3 PL07874300T PL07874300T PL2209789T3 PL 2209789 T3 PL2209789 T3 PL 2209789T3 PL 07874300 T PL07874300 T PL 07874300T PL 07874300 T PL07874300 T PL 07874300T PL 2209789 T3 PL2209789 T3 PL 2209789T3
- Authority
- PL
- Poland
- Prior art keywords
- hcv ns5b
- ns5b inhibitors
- cyclopropyl fused
- fused indolobenzazepine
- indolobenzazepine hcv
- Prior art date
Links
- JYGUARFTLQSWDG-UHFFFAOYSA-N 3,12-diazatetracyclo[9.7.0.02,8.013,18]octadeca-1,3,5,7,9,11,13,15,17-nonaene Chemical compound C1=CC=NC2=C3C4=CC=CC=C4N=C3C=CC2=C1 JYGUARFTLQSWDG-UHFFFAOYSA-N 0.000 title 1
- 101710112514 Host translation inhibitor 5b Proteins 0.000 title 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 241000711549 Hepacivirus C Species 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 3
- 239000000203 mixture Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US2007/085183 WO2009067108A1 (en) | 2007-11-20 | 2007-11-20 | Cyclopropyl fused indolobenzazepine hcv ns5b inhibitors |
| EP07874300A EP2209789B1 (en) | 2007-11-20 | 2007-11-20 | Cyclopropyl fused indolobenzazepine hcv ns5b inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2209789T3 true PL2209789T3 (pl) | 2012-04-30 |
Family
ID=40010653
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL07874300T PL2209789T3 (pl) | 2007-11-20 | 2007-11-20 | Skondensowane z cyklopropylem indolobenzoazepinowe inhibitory NS5B HCV |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP2209789B1 (pl) |
| JP (1) | JP5416710B2 (pl) |
| KR (1) | KR20100108341A (pl) |
| CN (1) | CN101918410B (pl) |
| AT (1) | ATE533771T1 (pl) |
| AU (1) | AU2007361468A1 (pl) |
| CY (1) | CY1112699T1 (pl) |
| DK (1) | DK2209789T3 (pl) |
| ES (1) | ES2375065T3 (pl) |
| MX (1) | MX2010005226A (pl) |
| PL (1) | PL2209789T3 (pl) |
| PT (1) | PT2209789E (pl) |
| SI (1) | SI2209789T1 (pl) |
| WO (1) | WO2009067108A1 (pl) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8129367B2 (en) * | 2007-11-21 | 2012-03-06 | Bristol-Myers Squibb Company | Compounds for the treatment of Hepatitis C |
| CN102046630A (zh) | 2008-03-27 | 2011-05-04 | 百时美施贵宝公司 | 吡咯烷稠合的吲哚并苯并二氮杂*hcv ns5b抑制剂 |
| JP2011515486A (ja) | 2008-03-27 | 2011-05-19 | ブリストル−マイヤーズ スクイブ カンパニー | Ｃ型肝炎の治療用化合物 |
| UY32099A (es) | 2008-09-11 | 2010-04-30 | Enanta Pharm Inc | Inhibidores macrocíclicos de serina proteasas de hepatitis c |
| UY33227A (es) | 2010-02-19 | 2011-09-30 | Novartis Ag | Compuestos de pirrolopirimidina como inhibidores de la cdk4/6 |
| CA2822556A1 (en) | 2010-12-30 | 2012-07-05 | Enanta Pharmaceuticals, Inc | Macrocyclic hepatitis c serine protease inhibitors |
| US8951964B2 (en) | 2010-12-30 | 2015-02-10 | Abbvie Inc. | Phenanthridine macrocyclic hepatitis C serine protease inhibitors |
| US10201584B1 (en) | 2011-05-17 | 2019-02-12 | Abbvie Inc. | Compositions and methods for treating HCV |
| US9556204B2 (en) * | 2012-07-18 | 2017-01-31 | Bristol-Myers Squibb Company | Methods and intermediates for the preparation of (4bS,5aR)-12-cyclohexyl-N-(N,N-dimethylsulfamoyl)-3-methoxy-5a-((1R,5S)-3-methyl-3,8-diazabicyclo [3.2.1]octane-8-carbonyl)-4b,5,5a,6-tetrahydrobenzo [3,4]cyclopropa[5,6]azepino[1,2-A]indole-9-carboxamide |
| WO2015103490A1 (en) | 2014-01-03 | 2015-07-09 | Abbvie, Inc. | Solid antiviral dosage forms |
| US11338043B2 (en) | 2016-02-08 | 2022-05-24 | Synaffix B.V. | Antibody-conjugates with improved therapeutic index for targeting HER2 tumours and method for improving therapeutic index of antibody-conjugates |
| US11951175B2 (en) | 2016-02-08 | 2024-04-09 | Synaffix B.V. | Bioconjugates containing sulfamide linkers for use in treatment |
| WO2017137423A1 (en) | 2016-02-08 | 2017-08-17 | Synaffix B.V. | Improved sulfamide linkers for use in bioconjugates |
| WO2017157735A1 (de) | 2016-03-15 | 2017-09-21 | Bayer Cropscience Aktiengesellschaft | Substituierte sulfonylamide zur bekämpfung tierischer schädlinge |
| TW201822637A (zh) | 2016-11-07 | 2018-07-01 | 德商拜耳廠股份有限公司 | 用於控制動物害蟲的經取代磺醯胺類 |
| CN114641467A (zh) | 2019-11-07 | 2022-06-17 | 拜耳公司 | 用于防治动物有害物的取代的磺酰胺 |
| US12274700B1 (en) | 2020-10-30 | 2025-04-15 | Accencio LLC | Methods of treating symptoms of coronavirus infection with RNA polymerase inhibitors |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100387580C (zh) * | 1997-09-29 | 2008-05-14 | 明治制果株式会社 | 三环三唑并苯并氮杂䓬衍生物、用于制备该衍生物的方法和抗变态反应剂 |
| US7399758B2 (en) * | 2005-09-12 | 2008-07-15 | Meanwell Nicholas A | Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors |
| US7473688B2 (en) * | 2005-09-13 | 2009-01-06 | Bristol-Myers Squibb Company | Indolobenzazepine HCV NS5B inhibitors |
| US7521443B2 (en) * | 2006-05-17 | 2009-04-21 | Bristol-Myers Squibb Company | Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors |
| US7456166B2 (en) * | 2006-05-17 | 2008-11-25 | Bristol-Myers Squibb Company | Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors |
| DE602007006796D1 (de) * | 2006-05-25 | 2010-07-08 | Bristol Myers Squibb Co | Cyclopropyl-fusionierte indolbenzazepin-hcv-ns5b-hemmer |
| EP2121707B1 (en) * | 2006-12-20 | 2012-12-05 | Istituto di Ricerche di Biologia Molecolare P. Angeletti S.R.L. | Antiviral indoles |
| US7541351B2 (en) * | 2007-01-11 | 2009-06-02 | Bristol-Myers Squibb Company | Compounds for the treatment of hepatitis C |
| CN101679437B (zh) * | 2007-03-13 | 2013-04-17 | 百时美施贵宝公司 | 环丙基稠合的吲哚并苯并氮杂*hcv ns5b抑制剂 |
| US7541353B2 (en) * | 2007-03-14 | 2009-06-02 | Bristol-Myers Squibb Company | Compounds for the treatment of hepatitis C |
| US7547690B2 (en) * | 2007-03-14 | 2009-06-16 | Bristol-Myers Squibb Company | Compounds for the treatment of Hepatitis C |
| US7521444B2 (en) * | 2007-03-14 | 2009-04-21 | Bristol-Myers Squibb Company | Compounds for the treatment of hepatitis C |
| US7538102B2 (en) * | 2007-03-14 | 2009-05-26 | Bristol-Myers Squibb Company | Compounds for the treatment of Hepatitis C |
| US7642251B2 (en) * | 2007-08-09 | 2010-01-05 | Bristol-Myers Squibb Company | Compounds for the treatment of hepatitis C |
| US7652004B2 (en) * | 2007-08-09 | 2010-01-26 | Bristol-Myers Squibb Company | Compounds for the treatment of hepatitis C |
-
2007
- 2007-11-20 CN CN2007801022148A patent/CN101918410B/zh not_active Expired - Fee Related
- 2007-11-20 EP EP07874300A patent/EP2209789B1/en not_active Not-in-force
- 2007-11-20 PL PL07874300T patent/PL2209789T3/pl unknown
- 2007-11-20 KR KR1020107013455A patent/KR20100108341A/ko not_active Ceased
- 2007-11-20 MX MX2010005226A patent/MX2010005226A/es active IP Right Grant
- 2007-11-20 DK DK07874300.2T patent/DK2209789T3/da active
- 2007-11-20 JP JP2010534924A patent/JP5416710B2/ja not_active Expired - Fee Related
- 2007-11-20 SI SI200730855T patent/SI2209789T1/sl unknown
- 2007-11-20 ES ES07874300T patent/ES2375065T3/es active Active
- 2007-11-20 WO PCT/US2007/085183 patent/WO2009067108A1/en not_active Ceased
- 2007-11-20 AT AT07874300T patent/ATE533771T1/de active
- 2007-11-20 AU AU2007361468A patent/AU2007361468A1/en not_active Abandoned
- 2007-11-20 PT PT07874300T patent/PT2209789E/pt unknown
-
2012
- 2012-02-14 CY CY20121100152T patent/CY1112699T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2375065T3 (es) | 2012-02-24 |
| PT2209789E (pt) | 2012-01-16 |
| EP2209789A1 (en) | 2010-07-28 |
| SI2209789T1 (sl) | 2012-06-29 |
| KR20100108341A (ko) | 2010-10-06 |
| MX2010005226A (es) | 2010-05-27 |
| CN101918410A (zh) | 2010-12-15 |
| CY1112699T1 (el) | 2016-02-10 |
| CN101918410B (zh) | 2013-02-27 |
| DK2209789T3 (da) | 2012-03-05 |
| EP2209789B1 (en) | 2011-11-16 |
| JP5416710B2 (ja) | 2014-02-12 |
| JP2011503229A (ja) | 2011-01-27 |
| ATE533771T1 (de) | 2011-12-15 |
| WO2009067108A1 (en) | 2009-05-28 |
| AU2007361468A1 (en) | 2009-05-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SI2209789T1 (sl) | Ciklopropil zliti indolobenzazepin hcv ns5b inhibitorji | |
| PL1987038T3 (pl) | Inhibitory HCV NS5B | |
| WO2007140200A3 (en) | Cyclopropyl fused indolobenzazepine hcv ns5b inhibitors | |
| WO2007140254A3 (en) | Cyclopropyl fused indolobenzazepine hcv ns5b inhibitors | |
| TW200745035A (en) | Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors | |
| TW200745120A (en) | Indolobenzazepine HCV NS5B inhibitors | |
| IL195025A (en) | History of compressed indolubenzazepine with cyclopropyl and pharmaceuticals containing them as an anti-hcv drug | |
| MX2011009644A (es) | Inhibidores del virus de la hepatitis c. | |
| MY152070A (en) | Macrocyclic quinxaline compounds as hcv ns3 protease inhibitors | |
| MX2010001416A (es) | Compuesto para el tratamiento de la hepatitis c. | |
| MX2013002927A (es) | Inhibidores del virus de la hepatitis c. | |
| ATE522532T1 (de) | Verbindungen zur behandlung von hepatitis c | |
| MX2009009473A (es) | Compuestos para el tratamiento de hepatitis c. | |
| EA201270555A1 (ru) | Комбинации ингибиторов вируса гепатита с | |
| MX2011006631A (es) | Inhibidores de proteasa ns3 del virus hcv. | |
| MX2009004556A (es) | Inhibidores de la proteasa ns3 del hcv. | |
| ATE494291T1 (de) | Verbindungen zur behandlung von hepatitis c | |
| MX2012004032A (es) | Compuestos para el tratamiento de hepatitis c. | |
| EA201000948A1 (ru) | Ингибиторы вирусной полимеразы | |
| MX2012008443A (es) | Nucleosidos antiviricos. | |
| ATE551343T1 (de) | Tetracyclische verbindungen zur behandlung von hepatitis c | |
| ATE505473T1 (de) | Cyclopropylkondensierte indolobenzazepinderivate zur behandlung von hepatitis c | |
| MX2013004464A (es) | Inhibidores de polimerasa viral. | |
| MX2010010061A (es) | Compuestos para el tratamiento de hepatitis c. | |
| MX2010010235A (es) | Inhibidores de ns5b de virus de la hepatitis c de indolobenzadiazepina fusionados a pirrolidina. |